Event Description

Global Vaccines Innovation and Immunology Conference (Hybrid Event) September 21-23, 2026 London, UK & Online (GVX 2026) is an international gathering designed to spotlight the latest advancements, challenges, and future directions in the field of vaccines. Bringing together researchers, public health officials, biotech innovators, policymakers, and industry leaders, the conference provides a comprehensive platform for exploring breakthrough research and global immunization strategies. Vaccine Conference 2026 emphasizes the critical importance of vaccine technology in strengthening worldwide health systems and preparing for emerging infectious threats.

This hybrid event allows participants to join either onsite in London or virtually from any location, making it accessible for a truly global audience. Attendees can expect keynote addresses from leading vaccine scientists, interactive panels on manufacturing scalability, workshops on regulatory pathways, and discussions on digital health tools that enhance vaccine distribution. A special focus will be placed on mRNA advancements, AI-driven vaccine discovery, and the role of global collaborations in expanding vaccine equity.

Immunology Congress also offers ample networking opportunities, including expert roundtables, start-up showcases, and B2B meetings. Exhibitors will present new technologies, diagnostic tools, and vaccine delivery systems, giving participants insights into the innovations transforming immunization programs worldwide.

Designed for professionals across public health, academia, biotech, and pharmaceutical sectors, Immunization Conferences is the ideal forum for sharing knowledge and shaping the future of vaccines. Whether attending in person or online, participants will gain valuable insights into the evolving landscape of immunization science and global health preparedness.